Vous êtes sur la page 1sur 20

N

E
U
L
F
IN
W

A
Z
K

INFLUENZA (FLU)
a viral infection that can be caused by
a number of different influenza strains
affects mainly the nose, throat, bronchi
and, occasionally, lungs
Infection usually lasts for a week

who.int/topics/influenza

INFLUENZA (FLU)
characterized by
sudden onset of high fever,
aching muscles
headache
severe malaise
non-productive cough
sore throat
rhinitis
who.int/topics/influenza

HOW IS IT TRANSMITTED?
via droplets and small particles produced
when infected people cough or sneeze
when someone touches a surface
contaminated with the virus
Adults shed the infectious influenza virus
1-2 days before any symptoms appear

CDC Epidemiology and Prevention of


Vaccine-Preventable Diseases 2012

INFLUENZA DISEASE BURDEN IN THE UNITED STATES IN AN AVERAGE YEAR

Hospitalizations*

Deaths*
3,000 to 49,000

117,000 to 816,000

Physician visits
~25 million
Infections and illnesses
50 to 60 million

ll-cause hospitalization and mortality associated with influenza virus infection.

Thompson WW et al. JAMA. 2003;289:179-186; Thompson WW et al. JAMA. 2004;292:1333-1340;


Couch RB. Ann Intern Med. 2000;133:992-998; Patriarca PA. JAMA. 1999;282:75-77; ACIP. MMWR. 2004;53(RR06):1-40;
MMWR. 2010; 59(33): 1057-1062.

INFLUENZA UPDATE
In tropical Asia, countries in Southern
Asia reported elevated but decreasing
influenza activity with influenza
A(H3N2) predominating.

who.int/influenza/surveillance_monitoring

HOW TO PREVENT INFLUENZA?

6 MONTHS+
Everyone 6
months of age
and older
should get
vaccinated
against the flu.

TAKE
PRECAUTIONS

ANTIVIRAL
MEDICATIONS

Take everyday
precautions, like
washing your
hands, to protect
your health.

Take everyday
precautions, like
washing your hands,
to protect your
health.
flu.gov/preventionvaccination/prevention

FLU VACCINE
Recommended for prophylaxis
against influenza in adults and
children older than 6 months old

FLUARIX

FLUARIX is a suspension for injection.


Each 0.5mL dose is supplied in single
dose prefilled TIP-LOK syringes

FLUARIX
INDICATION
indicated for active immunization for the
prevention of disease caused by influenza
A subtype viruses and type B virus
contained in the vaccine
Approved for use in persons 3 years of age
and older

FLUARIX
DOSAGE & ADMINISTRATION
AGE

Aged 3 through 8
years

Aged 9 years and

VACCINATION
STATUS

DOSE & SCHEDULE

Not previously
vaccinated with
influenza vaccine

Two doses (0.5-mL


each)
at least 4 weeks apart

Vaccinated with
influenza
vaccine in a previous
season

One or two doses a


(0.5mL each)

Not applicable

One 0.5-mL dose

preferred
site for intramuscular injection is the deltoid muscle of
older
the upper arm.

FLUARIX

Should be administered before the beginning


of the influenza season or as required by the
epidemiological situation

Should be repeated every year with an age


appropriate dose of vaccine of updated
antigen composition

Can be administered intramuscularly or


subcutaneously (esp. in patients with
bleeding disorder)

WARNING AND PRECAUTIONS


Should be postponed in patients suffering
from acute severe febrile illness
Will only prevent disease caused by
influenza virus
Infections with other agents causing flulike symptoms are not prevented by the
vaccine

WARNING AND PRECAUTIONS


Syncope/ fainting can occur before
or after vaccination (psychogenic
response to the needle injection)

Should be used during pregnancy


only when clearly needed, and the
possible advantages outweigh the
potential risks for the foetus

VAXIGRIP

VAXIGRIP Prefilled syringe containing 0.5 mL of vaccine (Packs of


1 or 10 syringes )
VAXIGRIP Junior
Prefilled syringe containing 0.25 mL of vaccine
(Pack of 1 syringe )

VAXIGRIP
INDICATION
indicated for the prevention of influenza
caused by Influenza Virus types A and B in
adults and children aged 6 months and over
VAXIGRIP Junior is indicated in children
aged 6 months to 35 months requiring a
0.25 mL dose

VAXIGRIP
not be given to persons with known systemic
hypersensitivity reactions to egg proteins
(eggs or egg products), chicken proteins, any
other component of the vaccine
Vaccination must be postponed in case of
febrile or acute disease
Vaccine must be used with caution to patients
with history of Guillain-Barr Syndrome (GBS)

VAXIGRIP
Must be used with caution to patients
with bleeding disorder
should be given to a pregnant woman
following an assessment of the risks
and benefits
should used when administering
vaccine to breastfeeding women

VACCINE INFORMATION
Adverse events after

vaccination

Local Reactions:
pain

redness
swelling
Muscle aches
Headache
Malaise

Fever
Allergic reactions:

<1 in

centracare.org/florida